Skip to content
Finance Investment, Oil Mining Resources

High-priority drill targets identified at Star Range Silver-Antimony Project in Utah

Jane Morgan Management 2 mins read

18 March 2026
Perth, Australia

Diablo Resources Limited (ASX:DBO) has identified high-priority drill targets at its 100% owned Star Range Silver-Antimony Project in Utah, following completion of an Induced Polarisation (IP) survey at the North Star Prospect.

The survey has outlined multiple chargeability and conductivity anomalies that coincide with known high-grade surface mineralisation and favourable geological structures, supporting the Company’s plans for a maiden drilling program in Q2 2026.

The newly defined targets align with the STAR-01 magnetic anomaly and are located proximal to an intrusive–sediment contact, a setting recognised as highly prospective for mineralisation.

Surface sampling at North Star has previously returned high-grade results including up to 3,043 g/t silver and 0.7% antimony, reinforcing the prospectivity of the system.

Importantly, the target area remains untested by drilling, presenting a first-mover opportunity to evaluate the scale and continuity of the mineralised system.

The IP program, comprising approximately 9 line-kilometres of surveying, has defined three priority drill areas targeting chargeability and conductivity anomalies interpreted to be associated with sulphide mineralisation at depth.

Planned drilling will also test high-grade veins and breccia zones identified at surface, forming the foundation of Diablo’s maiden drill campaign.

CEO Lyle Thorne commented:

“We are very encouraged by the results of the IP survey completed at North Star. The survey has outlined clear anomalies of interest that coincide with known mineralisation and highly prospective geological settings, further reinforcing our view that the North Star Prospect represents a priority drill target.

The addition of these new geophysical targets provides valuable flexibility in shaping our exploration strategy as we progress toward our maiden drill program.

Silver is increasingly recognised both as a precious and strategic metal, with growing demand from defence systems, electric vehicles, solar panels, AI data centres, and 5G infrastructure. We are committed to participating in the United States’ domestic efforts to secure reliable supplies of critical minerals.”

The Star Range Project is located in Beaver County, Utah, approximately 6km from the town of Milford and near historical and operating mining centres, including the Horn Silver Mine and Milford Copper Mine.

The region has a long history of base and precious metals production and hosts favourable geology including structurally controlled mineralisation and intrusive-related systems.

Next steps include finalising drill program design and logistics, submitting permitting applications, and continuing regional geochemical exploration across the broader project area.


About us:

About Diablo Resources

Diablo Resources Limited (ASX: DBO, OTCQB: DBORF) is an exploration company focused on the discovery and development of critical minerals projects in the United States. The Company’s portfolio includes the Star Range Silver-Antimony Project in Utah, where exploration is targeting high-grade silver and antimony mineralisation associated with structurally controlled mineral systems.

Diablo’s strategy is to advance high-quality projects in mining-friendly jurisdictions with strong infrastructure and increasing demand for critical minerals essential to modern technologies and supply chain security.

 


Contact details:

Jane Morgan
Investor and Media Relations
JMM
[email protected]
+61 405 555 618

Media

More from this category

  • Finance Investment, Oil Mining Resources
  • 18/03/2026
  • 10:00
Jane Morgan Management

Titan Minerals grows Dynasty Gold Project resource to 3.9Moz gold and 26.1Moz silver

Key Facts: Substantial resource upgrade delivered at 100%-owned Dynasty Gold Project in southern Ecuador, reinforcing its emergence as a large-scale, multi-deposit gold-silver system that stands out among a selection of global ASX peers as shown overleaf. The updated global resource now stands at 65.6Mt @ 1.85g/t Au & 12.38g/t Ag for 3.9Moz of gold and 26.1Moz of silver (CGe: 4.3Moz @ 2.05g/t AuEq in-situ at spot). This represents a 25% increase in gold and a 19% increase in silver relative to the 2023 estimate, driven primarily by drilling success and growth at the Cerro Verde deposits.Press Release18 March 2026 Resource…

  • Contains:
  • Finance Investment
  • 18/03/2026
  • 09:30
Independent Reserve

Aussie crypto ownership hits record highs despite rising bank payment blocks, survey reveals

Aussie crypto ownership hits record highs despite rising bank payment blocks, survey reveals TheIndependent Reserve Cryptocurrency Index (IRCI) has just been published for 2026. Now in its seventh year, the annual survey of more than 2,000 everyday Australians is designed to reflect the country’s population across age, gender, and location. The 2026 index score edged down slightly to 53 from 54 the previous year, measuring national sentiment across awareness, adoption, trust, and confidence in cryptocurrency. Crypto adoption hits record levels: 33% of Australians now own cryptocurrency, up 31% from 2025. Banks are increasingly blocking crypto payments: 30% of Aussie investors…

  • Finance Investment, Medical Health Aged Care
  • 17/03/2026
  • 10:25
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step in the transfer of the StemSmart™ manufacturing process to a large-scale clinical contract manufacturer that is then capable of providing adequate supply for Phase 2 clinical trials and future commercialisation. Q-Gen Cell Therapeutics, located within the QIMR Berghofer Medical Research Institute in Brisbane, is one…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.